Achieve

ACHV NASDAQ
3.800
+0.170
+4.68%
Opening 13:29 05/24 EDT
Open
3.650
Prev Close
3.630
High
3.800
Low
3.650
Volume
79.96K
Avg Vol (3M)
609.15K
52 Week High
14.31
52 Week Low
1.045
% Turnover
1.16%
Market Cap
26.09M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Related

Webull offers Achieve ACHV stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company engaged in the development and commercialization of cytisine for smoking cessation. The Company’s focus is to address the global smoking health epidemic, which is the leading cause of preventable death and is responsible for nearly six million deaths annually worldwide. Cytisine is an established 25 day smoking cessation treatment that has been approved and marketed in Central and Eastern Europe by a third party for over 20 years under the brand name TabexTM. As of December 2016, it is estimated that over 21 million people have used cytisine to help combat nicotine addiction, including over 2,000 patients in investigator-conducted, Phase III clinical trials in Europe and New Zealand.
MORE >

Recently

Name
Price
%Change